Rotator cuff tear, osteoporosis
Conditions
Interventions
Teriparatide acetate group
Control group
Sponsors
Department of Orthpaedic Surgery, Fukuoka University Chikushi Hospital
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1) Patients of 50 y.o or older female. 2) Patients who underwent surgery in our hospital. 3) Patients who had been diagnosed with rotator cuff tear and osteoporosis. 4) Patients with rotator cuff tear size is large or more. 5) Patients who obtained the consent in this study. 6) Patients who were able to complete the surgery by suture bridge technique under arthroscopic.
Exclusion criteria
Exclusion criteria: 1) Patients with intrinsic disease (osteoarthritis, rheumatoid arthritis, calcific tendinitis, infection, metabolic disorders etc) 2) Patients with metabolic diseases (hypercalcemia, hyperparathyroidism, hypothyroidism etc) 3) Extrinsic disease (trauma, after surgery, neuromuscular diseases, congenital malformation etc) 4) Patients with cervical disease 5) Patients with severe diabetes mellitus 6) Patients with liver failure, renal failure and with the history. 7) Patients with malignant tumor or metastatic tumor. 8) Workers' compensation patients 9) Patients with skin disease or infection at the injection site 10) Patients with a history of allergy to the components of this drug.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| At postoperative 12 weeks of ARCR, the healing rate and cuff integrity of the repaired rotator cuff compared with the control group and teriparatide acetate group. | — |
Secondary
| Measure | Time frame |
|---|---|
| The Pain by visual analog scale, Constant score, JOA score and WORC index compare with the control group and teriparatide acetate group. | — |
Countries
Japan
Contacts
Public ContactTomohiko Minamikawa
Fukuoka University Chikushi Hospital Department of Orthpaedic Surgery
Outcome results
None listed